Key Dates

Related Announcements

RFA-CA-22-042 - Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

This Notice corrects the Table for Application Due Dates in RFA-CA-22-042, Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional).

The following section of RFA-CA-22-042 has been corrected:

Part 1. Overview Information, Key Dates

Currently reads:

Expiration Date: October 17, 2023

Corrected to read (in bold italics):

Expiration Date: October 16, 2023

All other aspects of RFA-CA-22-042 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Rachel Grana Mayne, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-5899
Email: rachel.mayne@nih.gov

Kevin Walton, PhD
National Institute on Drug Abuse (NIDA)
Phone: 301-827-5980
E-mail: kevin.walton@nih.gov

Evan Sullivan Herrmann, PhD
National Institute on Drug Abuse (NIDA)
Phone: 301-443-1428
E-mail: evan.herrmann@nih.gov

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov

Financial/Grants Management Contact(s)

Dawn Mitchum
National Cancer Institute (NCI)
Telephone: 240-276-5699
Email: dm437a@nih.gov

Amy Connolly
National Institute on Drug Abuse (NIDA)
Phone: (301) 827-4457
E-mail: connolla@mail.nih.gov